West Pharmaceutical Services (WST) Shares Outstanding (Diluted Average) (2009 - 2026)

West Pharmaceutical Services' Shares Outstanding (Diluted Average) history runs 17 years deep, the most recent figure standing at $72.4 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 0.82% year-over-year to $72.4 million; the TTM figure through Mar 2026 stood at $72.4 million (down 0.82% YoY), while the FY2025 annual figure was $72.7 million, down 1.36% from the prior year.
• Shares Outstanding (Diluted Average) came in at $72.4 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $72.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $76.0 million in Q1 2022 to a low of $72.4 million in Q1 2026.
• A 5-year average of $74.3 million and a median of $74.3 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) climbed 0.26% in 2022 and retreated 2.52% in 2024, its largest moves.
• West Pharmaceutical Services' Shares Outstanding (Diluted Average) stood at $75.8 million in 2022, then dropped by 0.66% to $75.3 million in 2023, then declined by 2.12% to $73.7 million in 2024, then slipped by 1.36% to $72.7 million in 2025, then decreased by 0.41% to $72.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $72.4 million, $72.7 million, and $72.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison